Biomarker Discovery Services
Expert Biomarker Discovery Services using cutting-edge technologies such as high-quality proteomics with Proximity Extension Assay (PEA) technology from Olink, and ultra-sensitive detection with proven Simoa technology. We offer ideal broad screening-to-targeted biomarker discovery solutions in different therapeutic areas.
Receive your quote directly from the manufacturer.
We provide protein biomarkers discovery services that have the potential to identify novel drug targets in the early stages. The pharmaceutical industry relies heavily on these markers to uncover disease progression, responder signatures, diagnostic biomarkers, and potential new indications. The role of biomarkers in drug development is crucial as they provide valuable insights into the efficacy and safety of potential drug candidates.
1. High-Quality Proteomics - Olink® PEA technology (Olink Certified Service Provider):
- Olink Target 96
- Olink Target 48
- Olink Flex
- Olink Focus
2. Ultra-sensitive detection - Simoa™ technology:
Utilizing high-quality single-molecule arrays (SimoaTM) technology, we can support your exploratory biomarker detection in a variety of biological matrices with a sensitivity in the femtomolar range, well below the detection limit of the best ELISAs.
Simoa assays are available in the following therapeutic areas: COVID-19, neurology, oncology, immunology, cardiology, and infectious diseases.
In addition, utilizing our 30 years of assay development experience, we can support you in developing high-quality Simoa-based assays for your specific needs.
